Tuning the binding interface between Machupo virus glycoprotein and human transferrin receptor

Area of Science:

• Virology and Molecular Biology
• Biotechnology and Drug Delivery

Background:

• Machupo virus uses its glycoprotein (MGP1) to bind transferrin receptor 1 (TfR) for cell entry.
• TfR interactions are explored for ferrying therapeutics across cellular membranes and the blood-brain barrier.
• Previous studies identified key residues but did not optimize MGP1-TfR binding.

Purpose of the Study:

• To understand the structure-sequence relationship governing MGP1-TfR interface formation.
• To optimize MGP1 binding affinity to TfR for potential biotechnological applications.
• To engineer MGP1 variants for enhanced cellular internalization and blood-brain barrier crossing.

Main Methods:

• Yeast surface display of MGP1 to examine residue contributions to TfR binding.
• Identification of MGP1 binding hot spots and assessment of N-glycan modification importance.
• Affinity maturation using random mutagenesis and selection of optimized MGP1 variants.

Main Results:

• Identified key MGP1 residues crucial for TfR binding.
• Demonstrated that optimized MGP1 variants exhibit stronger TfR binding than native MGP1.
• Developed a glycosylation-independent MGP1 variant with additional amino acid substitutions.

Conclusions:

• Optimized MGP1 variants can enhance TfR-mediated cellular internalization.
• Engineered MGP1 holds potential for targeted drug delivery across the blood-brain barrier.
• Understanding MGP1-TfR interactions is vital for developing New World arenavirus therapeutics.